As of April 2024 Biohaven Pharmaceutical has a market cap of $3.43 Billion. This makes Biohaven Pharmaceutical the world's 3207th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $3.43 B | 0.16% |
2023 | $3.43 B | 262.97% |
2022 | $0.94 B | -89.52% |
2021 | $9.02 B | 75.71% |
2020 | $5.13 B | 80.14% |
2019 | $2.85 B | 74.49% |
2018 | $1.63 B | 68.19% |
2017 | $0.97 B |
On Apr 25th, 2024 the market cap of Biohaven Pharmaceutical was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.54 B | -84.19% | ๐บ๐ธ USA |